NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,452 | +0.9% | 3,146 | 0.0% | 0.22% | +3.9% |
| Q2 2023 | $317,463 | +9.7% | 3,146 | 0.0% | 0.21% | +3.5% |
| Q1 2023 | $289,432 | +3.3% | 3,146 | +1.9% | 0.20% | -2.9% |
| Q4 2022 | $280,143 | +18.7% | 3,088 | -0.6% | 0.21% | +12.6% |
| Q3 2022 | $236,000 | +15.1% | 3,107 | +33.0% | 0.18% | +39.7% |
| Q1 2022 | $205,000 | +0.5% | 2,336 | 0.0% | 0.13% | +3.1% |
| Q4 2021 | $204,000 | +41.7% | 2,336 | +40.6% | 0.13% | +4.1% |
| Q3 2019 | $144,000 | -16.8% | 1,662 | -12.2% | 0.12% | -19.2% |
| Q2 2019 | $173,000 | -1.7% | 1,892 | +3.4% | 0.15% | -5.6% |
| Q1 2019 | $176,000 | +11.4% | 1,830 | 0.0% | 0.16% | -1.2% |
| Q4 2018 | $158,000 | 0.0% | 1,830 | 0.0% | 0.16% | +16.5% |
| Q3 2018 | $158,000 | +13.7% | 1,830 | 0.0% | 0.14% | +7.8% |
| Q2 2018 | $139,000 | – | 1,830 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |